BURLINGTON, Ontario--(BUSINESS WIRE)--$ELMT--Element Nutritional Sciences Inc. (CSE:ELMT; OTC:ELNSF; FRANKFURT:93X) (the “Company” or “Element”), is pleased to announce that the clinically proven amino acid formulation used in its Rejuvenate™ muscle health products received a global Patent Cooperation Treaty (“PCT”) patent issued by the United States Patent and Trademark Office on March 15, 2022. This patent extends Element’s intellectual property protection for “the amino acid composition for stimulating muscle protein synthesis” beyond the Unites States into foreign markets including, but not limited to, Canada, the European Union and the Asia Pacific countries.
This is the first global patent to be issued in the muscle health industry for a product that increases muscle protein synthesis. The patent will cover the amino acid formulation in both the Company’s brands, Rejuvenate™ and Promino™, and will support the launch of Promino™ into professional sports and the US$14 billion1 sports nutrition industry. Global patent protection will further support the Company’s extension into institutional markets, such as hospitals and long-term care.
“One of our most valuable differentiating factors is the quality of the formulation that underpins our Rejuvenate™ and Promino™ products. Not only is it clinically proven to improve muscle health, but it is now fully patented which provides a clear competitive advantage versus other products that claim to improve muscle health. This patent also supports Element’s global ambitions as the Company strives to enhance peoples’ lives by maintaining muscle health and improving quality of life,” commented Stuart Lowther, Chief Executive Officer.
The PCT patent may be viewed here, and the patent number is WO2019/090061.
About Element
Element is an innovative and research driven Canadian nutraceutical company specializing in the development of science-based products for the global consumer packaged goods market, with a portfolio focused specifically on men and women over the age of 50. Element’s lead product, Rejuvenate™, is a proprietary formulation that is clinically proven to assist in the rebuilding, restoration and rejuvenation of natural loss of muscle mass due to aging or other medical conditions. Element also offers JAKTRX™, an elite brand of performance supplements. Element was founded in 2015 and is located in Burlington, Ontario.
To learn more about Element, visit elmtinc.com.
More information about Rejuvenate™ can be found at: www.rejuvenatemuscle.com
More information about JAKTRX™ and Promino™ can be found at: www.jaktrx.com
Forward Looking Statements
This news release contains "forward-looking information" and "forward-looking statements" (collectively, "forward looking statements") within the meaning of the applicable Canadian securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Any statement that involves discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions, future events or performance (often but not always using phrases such as “expects”, or “does not expect”, “is expected”, “anticipates” or “does not anticipate”, “plans”, “budget”, “scheduled”, “forecasts”, “estimates”, “believes” or “intends” or variations of such words and phrases or stating that certain actions, events or results “may” or “could”, “would”, “might” or “will” be taken to occur or be achieved) are not statements of historical fact and may be forward-looking statements. In this news release, forward looking statements relate, among other things, to: the patent’s ability to provide protection against the Company’s intellectual property and the ability of the Company to enter institutional markets.
These forward-looking statements are based on reasonable assumptions and estimates of management of the Company at the time such statements were made. Actual future results may differ materially as forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to materially differ from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors, among other things, include: fluctuations in general macroeconomic conditions; expectations regarding the size of the United States and Canadian health, nutraceutical and wellness markets and changing consumer habits; the viability of the Company’s products; availability of distribution channels for the Company’s product offerings; the ability of the Company to successfully achieve its business objectives; plans for expansion; successful development of the Company’s proposed products; the presence of laws and regulations that may impose restrictions or recalls on the sale of the Company’s products in the United States and Canada; customer and distributor relations; fluctuations in securities markets; and the inability of the Company to obtain adequate insurance to cover risks and hazards. Although the forward-looking statements contained in this news release are based upon what management of the Company believes, or believed at the time, to be reasonable assumptions, the Company cannot assure shareholders that actual results will be consistent with such forward-looking statements, as there may be other factors that cause results not to be as anticipated, estimated or intended. Readers should not place undue reliance on the forward-looking statements and information contained in this news release. The Company assumes no obligation to update the forward-looking statements of beliefs, opinions, projections, or other factors, should they change, except as required by law.
No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.
1 North America Sports Nutrition Market | 2021 - 2026 | US, Canada, Mexico (marketdataforecast.com).
Contacts
Stuart Lowther
Chairman, CEO and President
ir@elementnutrition.com
416-467-5229
Marc Charbin
Investor Relations
ir@elementnutrition.com
416-467-5229